JP2017532369A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017532369A5 JP2017532369A5 JP2017530955A JP2017530955A JP2017532369A5 JP 2017532369 A5 JP2017532369 A5 JP 2017532369A5 JP 2017530955 A JP2017530955 A JP 2017530955A JP 2017530955 A JP2017530955 A JP 2017530955A JP 2017532369 A5 JP2017532369 A5 JP 2017532369A5
- Authority
- JP
- Japan
- Prior art keywords
- oral
- bromelain
- formulation
- diarrhea
- animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001465754 Metazoa Species 0.000 claims description 34
- 108010004032 Bromelains Proteins 0.000 claims description 19
- 239000004365 Protease Substances 0.000 claims description 19
- 235000019835 bromelain Nutrition 0.000 claims description 19
- 241000251468 Actinopterygii Species 0.000 claims description 16
- 230000000369 enteropathogenic effect Effects 0.000 claims description 16
- 244000005700 microbiome Species 0.000 claims description 16
- 238000009472 formulation Methods 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 241000282414 Homo sapiens Species 0.000 claims description 11
- 230000001142 anti-diarrhea Effects 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 239000002552 dosage form Substances 0.000 claims description 9
- 206010012735 Diarrhoea Diseases 0.000 claims description 8
- 239000002738 chelating agent Substances 0.000 claims description 6
- 239000003995 emulsifying agent Substances 0.000 claims description 6
- 239000006186 oral dosage form Substances 0.000 claims description 5
- 241000282412 Homo Species 0.000 claims description 4
- 230000000845 anti-microbial effect Effects 0.000 claims description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 3
- 208000015181 infectious disease Diseases 0.000 claims description 3
- 239000000787 lecithin Substances 0.000 claims description 3
- 235000010445 lecithin Nutrition 0.000 claims description 3
- 229940067606 lecithin Drugs 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 229920000623 Cellulose acetate phthalate Polymers 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 229940081734 cellulose acetate phthalate Drugs 0.000 claims description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 claims description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical class OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462041175P | 2014-08-25 | 2014-08-25 | |
| US62/041,175 | 2014-08-25 | ||
| PCT/US2015/046509 WO2016032944A1 (en) | 2014-08-25 | 2015-08-24 | Anti-diarrhea formulation which avoids antimicrobial resistance |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017532369A JP2017532369A (ja) | 2017-11-02 |
| JP2017532369A5 true JP2017532369A5 (cg-RX-API-DMAC7.html) | 2018-09-27 |
| JP6920199B2 JP6920199B2 (ja) | 2021-08-18 |
Family
ID=55400400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017530955A Expired - Fee Related JP6920199B2 (ja) | 2014-08-25 | 2015-08-24 | 抗微生物剤耐性を回避する抗下痢製剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20170239334A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3193629B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6920199B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102382930B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN106998749A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2015306904A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2959361A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3193629T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2938347T3 (cg-RX-API-DMAC7.html) |
| PH (1) | PH12017500338B1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016032944A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2995086T3 (en) * | 2019-10-11 | 2025-02-05 | Anatara Lifesciences Ltd | Gastrointestinal health composition |
| JP2023519170A (ja) * | 2020-03-12 | 2023-05-10 | アボット・ラボラトリーズ | 下痢または腸の炎症状態を治療する方法 |
| CN112618579B (zh) * | 2020-12-24 | 2022-02-15 | 南京农业大学 | 一种防治仔猪腹泻复合益生菌制剂和制备方法及应用 |
| CN116867498A (zh) * | 2021-02-16 | 2023-10-10 | 帝斯曼知识产权资产管理有限公司 | 用于通过选择性饲料添加剂干预减少致病性大肠杆菌的方法 |
| PL246387B1 (pl) * | 2022-08-16 | 2025-01-20 | Nutropharma Spolka Z Ograniczona Odpowiedzialnoscia | Kompozycja doustna i jej zastosowanie |
| KR102592953B1 (ko) * | 2023-01-30 | 2023-10-20 | 박예성 | 휴지기 없이 급여 가능한 반려동물용 영양제 제조공법 |
| CN116889261B (zh) * | 2023-07-22 | 2025-07-04 | 广东加大实业有限公司 | 一种防治腹泻乳猪饲料及其制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE106242T1 (de) * | 1986-08-28 | 1994-06-15 | Enzacor Pty Ltd | Mikrogranuläre zubereitung zur verabreichung biologisch aktiver stoffe in den eingeweideregionen von tieren. |
| JPH06511237A (ja) * | 1991-07-24 | 1994-12-15 | コ、トーマス サイ イーング | 治療用組成物およびその製造方法 |
| US6054261A (en) * | 1998-05-20 | 2000-04-25 | Q-Pharma, Inc. | Coenzyme Q10 compositions for organ protection during perfusion |
| US6080403A (en) * | 1998-06-18 | 2000-06-27 | Star-Kist Foods, Inc. | Protease containing hairball remedy and use thereof |
| ES2302913T3 (es) * | 2002-02-14 | 2008-08-01 | Dsm Ip Assets B.V. | Formulaciones a base de coenzima q-10. |
| CN1548154A (zh) * | 2003-05-22 | 2004-11-24 | 维奥（四川）生物技术有限公司 | 用于治疗哺乳动物腹泻的菠萝蛋白酶微胶囊化药物组合物 |
| US7351739B2 (en) * | 2004-04-30 | 2008-04-01 | Wellgen, Inc. | Bioactive compounds and methods of uses thereof |
| WO2008049437A1 (en) * | 2006-10-26 | 2008-05-02 | Biofiber-Damino A/S | Composition comprising lignin and antidi arrheal component |
| WO2009009879A1 (en) * | 2007-07-13 | 2009-01-22 | Aquience Inc. | Beverage composition for non-human animals |
| AT506095A1 (de) * | 2007-12-03 | 2009-06-15 | Volopharm Gmbh | Verwendung von proteasen |
| GB2480772B (en) * | 2009-01-06 | 2013-10-16 | Curelon Llc | Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus |
-
2015
- 2015-08-24 KR KR1020177008106A patent/KR102382930B1/ko active Active
- 2015-08-24 PH PH1/2017/500338A patent/PH12017500338B1/en unknown
- 2015-08-24 JP JP2017530955A patent/JP6920199B2/ja not_active Expired - Fee Related
- 2015-08-24 AU AU2015306904A patent/AU2015306904A1/en not_active Abandoned
- 2015-08-24 US US15/505,904 patent/US20170239334A1/en not_active Abandoned
- 2015-08-24 EP EP15836374.7A patent/EP3193629B1/en active Active
- 2015-08-24 ES ES15836374T patent/ES2938347T3/es active Active
- 2015-08-24 WO PCT/US2015/046509 patent/WO2016032944A1/en not_active Ceased
- 2015-08-24 CN CN201580045389.4A patent/CN106998749A/zh active Pending
- 2015-08-24 CA CA2959361A patent/CA2959361A1/en not_active Abandoned
- 2015-08-24 CN CN202111584816.XA patent/CN114711336A/zh active Pending
- 2015-08-24 DK DK15836374.7T patent/DK3193629T3/da active
-
2019
- 2019-06-26 AU AU2019204496A patent/AU2019204496B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017532369A5 (cg-RX-API-DMAC7.html) | ||
| JP4664678B2 (ja) | 抗菌性組成物および使用のための方法 | |
| JP6012111B2 (ja) | 動物用飼料添加物 | |
| JP2020023574A5 (ja) | 近視予防、治療又は抑制用点眼剤、及び、小胞体ストレス抑制用点眼剤 | |
| DK2224918T3 (en) | The use of EDTA and its salts for the prevention and treatment of bacterial intestinal diseases of pigs | |
| JP2017186306A (ja) | 魚介類の微胞子虫の防除用組成物及びそれを用いた魚介類の微胞子虫の防除方法 | |
| CN1636453A (zh) | 使用醌化合物制备杀生物的组合物和衍生组合物 | |
| JPWO2012002379A1 (ja) | 魚類の寄生虫駆除剤及び駆除方法 | |
| WO2023170183A1 (en) | Composition for treatment of parasitic or viral infection in alimentary and/or respiratory tract | |
| US20140287065A1 (en) | Oral Administration of Electrolyzed Water for Treatment and Prevention of PEDv in Swine, Swine Herds and Swine Confinements | |
| CN109568301A (zh) | 一种没食子酸、大黄酸复合配方制备方法及其应用 | |
| KR101544049B1 (ko) | 넙치 양식 어류 스쿠치카병 방제용 및 치료용 조성물 | |
| CN101199520A (zh) | 含丙磺舒的兽用β-内酰胺类抗生素复方制剂 | |
| CN101468025A (zh) | 一种用于防治禽大肠杆菌病的可溶性粉 | |
| JP2011182748A (ja) | 家畜又は家禽用飼料 | |
| JP2015030717A (ja) | 飼料添加物および飼料 | |
| JP2015523388A5 (cg-RX-API-DMAC7.html) | ||
| CN107279535A (zh) | 一种用于新生仔猪驱虫的饲料添加剂及生产方法 | |
| CN105541838B (zh) | 一种治疗肾结石的药物组合物 | |
| Dar et al. | Comparative therapeutic management of contagious ecthyma in small ruminants | |
| KR101314557B1 (ko) | 가축의 바이러스성 질환의 치료 또는 예방 방법 | |
| JP2016513738A5 (cg-RX-API-DMAC7.html) | ||
| JP2011084492A (ja) | 鶏舎又は畜舎の消毒方法 | |
| CN106727576A (zh) | 喹噁啉-1，4-二氧化物衍生物作为硫酸粘杆菌素增效剂的应用 | |
| CN109985022B (zh) | 聚维酮碘制剂及其制备方法和用途 |